How do I transfer my Waldenstrom Macroglobulinemia care to another hospital

Transferring Your Waldenstrom Macroglobulinemia Care to Another Hospital

I understand you're considering moving your care—this is an important decision for managing a rare condition like Waldenstrom macroglobulinemia (WM). Here's what you should know about the transfer process:

Why This Matters for WM

According to the NCCN Guidelines for Waldenström Macroglobulinemia, WM is a rare cancer, and even doctors who specialize in lymphoma may have seen few patients with this condition. Because of this, it's important to receive care from specialists experienced in treating WM—whether that's at a dedicated cancer center or a hospital with a strong hematology-oncology program.

Key Steps for Transferring Your Care

1. **Request Your [ID removed]

• Contact your current hospital's [ID removed] department
• Ask for:
  • All pathology reports (especially your bone marrow biopsy showing WM cells)
  • Genetic test results (MYD88 and CXCR4 mutation status—these are critical for treatment planning)
  • Imaging scans (CT or PET/CT results)
  • Blood test results and IgM levels over time
  • Treatment history and response assessments
  • Any complications you've experienced (neuropathy, hyperviscosity, etc.)

2. Find a WM-Experienced Center

The NCCN Guidelines recommend seeking care at:

• NCCN-affiliated cancer centers (find them at NCCN.org/member-institutions)
• International Waldenstrom's Macroglobulinemia Foundation (IWMF) directory (IWMF.com)—this lists physicians knowledgeable about WM

3. Schedule a Consultation

• Contact the new hospital's hematology-oncology department
• Mention you have WM and want to transfer care
• Some cancer centers now offer virtual second opinions if you can't travel
• Bring or have your records sent ahead of your first appointment

4. Coordinate the Handoff

• Ask your current doctor to send a summary letter to your new care team
• This should include:
  • Your diagnosis and staging information
  • Current treatment plan (if you're being treated)
  • Response to any previous treatments
  • Any complications or special considerations
  • Your MYD88 and CXCR4 mutation status

Important Considerations Specific to WM

According to the NCCN Guidelines, your new team will need to understand:

• Your mutation status: MYD88 and CXCR4 mutations significantly affect which treatments work best for you
• Your symptom history: WM can cause complications like peripheral neuropathy (nerve damage), hyperviscosity syndrome (blood thickening), or amyloidosis (abnormal protein buildup)
• Your treatment response: If you've been treated before, how you responded matters for choosing next-line therapy
• Your monitoring plan: If you're in watchful waiting (observation without treatment), your new team needs to know your baseline IgM levels and imaging findings

Questions to Ask Your New Care Team

When you meet with your new hospital:

1. "How much experience does your team have treating Waldenstrom macroglobulinemia?"
2. "Will I see the same oncologist each visit, or will I see different doctors?"
3. "How do you coordinate care if I need specialists (neurologist for neuropathy, ophthalmologist for vision problems, etc.)?"
4. "What's your approach to treatment decisions—do you use the NCCN Guidelines for WM?"
5. "Can I get a second opinion if I'm unsure about a treatment recommendation?"
6. "How will you monitor my disease between appointments?"

If You Don't Live Near a WM Specialist

The NCCN Guidelines for Patients note that some cancer centers provide virtual second opinions through their websites. This might be an option if:

• You want expert input but can't relocate
• You want to confirm your current treatment plan
• You need guidance on a specific complication

Timeline Considerations

• If you're in watchful waiting (no symptoms, just monitoring): You have time to find the right center
• If you're being treated: Coordinate the transfer carefully to avoid gaps in your therapy
• If you have complications (hyperviscosity, neuropathy): Prioritize finding experienced care quickly

Bottom Line

Transferring care for WM is absolutely reasonable and often beneficial. The key is ensuring your new team has access to your complete medical history—especially your genetic test results and treatment response data—so they can provide seamless, informed care.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.